title: Profiling Non-Small Cell Lung Cancer: From Tumor to Blood.
abstract: Circulating cell-free tumor DNA has shown great promise for noninvasive genomic profiling to guide the administration of targeted therapies in non-small cell lung cancer. With advancements in molecular technology, it is now possible to interrogate multiple clinically actionable genetic drivers in the blood with a single assay.
authors.affiliation: Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
authors.forename: Dana W Y
authors.initials: DW
authors.lastname: Tsui
authors.affiliation: Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York. bergerm1@mskcc.org.
authors.forename: Michael F
authors.initials: MF
authors.lastname: Berger
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics*; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics*; D009360:Neoplastic Cells, Circulating